Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / *W EXP 09/24/202
-
Total 13F shares
-
1,960,448
-
Share change
-
+12,204
-
Total reported value
-
$179,000
-
Price per share
-
$0.09
-
Number of holders
-
12
-
Value change
-
-$2,251
-
Number of buys
-
1
-
Number of sells
-
5
Institutional Holders of Jasper Therapeutics, Inc. - *W EXP 09/24/202 (JSPRW) as of Q2 2022
As of 30 Jun 2022,
Jasper Therapeutics, Inc. - *W EXP 09/24/202 (JSPRW) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,960,448 shares.
The largest 10 holders included
HIGHBRIDGE CAPITAL MANAGEMENT LLC, Owl Creek Asset Management, L.P., Ionic Capital Management LLC, TENOR CAPITAL MANAGEMENT Co., L.P., Shaolin Capital Management LLC, Privium Fund Management B.V., ZAZOVE ASSOCIATES LLC, EQUITEC PROPRIETARY MARKETS, LLC, HRT FINANCIAL LP, and COWEN AND COMPANY, LLC.
This page lists
12
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.